dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Albasanz-Puig, Adaia |
dc.contributor.author | Parody, Rocío |
dc.contributor.author | Tebé-Cordomí, Cristian |
dc.contributor.author | Akova, Murat |
dc.contributor.author | Araos, Rafael |
dc.contributor.author | Ruiz Camps, Isabel |
dc.contributor.author | Gudiol, Carlota |
dc.date.accessioned | 2019-08-08T06:29:24Z |
dc.date.available | 2019-08-08T06:29:24Z |
dc.date.issued | 2019-05-24 |
dc.identifier.citation | Albasanz-Puig A, Gudiol C, Parody R, Tebe C, Akova M, Araos R, et al. Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study. BMJ Open. 2019;9(5):e025744. |
dc.identifier.issn | 2044-6055 |
dc.identifier.uri | https://hdl.handle.net/11351/4254 |
dc.description | Bacterièmia; Infecció del torrent sanguini; Farmacoresistència múltiple |
dc.language.iso | eng |
dc.publisher | BMJ Publishing Group |
dc.relation.ispartofseries | BMJ Open;9(5) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Neutropènia |
dc.subject | Bacterièmia |
dc.subject | Pseudomones aeruginosa |
dc.subject | Microorganismes - Resistència als medicaments |
dc.subject.mesh | Neutropenia |
dc.subject.mesh | Bacteremia |
dc.subject.mesh | Pseudomonas aeruginosa |
dc.subject.mesh | /immunology |
dc.subject.mesh | Drug Resistance, Microbial |
dc.title | Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1136/bmjopen-2018-025744 |
dc.subject.decs | neutropenia |
dc.subject.decs | bacteriemia |
dc.subject.decs | Pseudomonas aeruginosa |
dc.subject.decs | /inmunología |
dc.subject.decs | farmacorresistencia microbiana |
dc.relation.publishversion | https://bmjopen.bmj.com/content/9/5/e025744 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Albasanz-Puig A, Gudiol C] Departament de Malalties Infeccioses, Hospital Universitari de Bellvitge, Barcelona, Spain. Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. Universitat de Barcelona, Barcelona, Spain. Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain. [Parody R] Departament d’hematologia, Institut Català d' Oncologia (ICO) Barcelona, Spain. Hospital Duran i Reynals, Barcelona, Spain. . Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. [Tebe C] Servei d’estadística, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. Universitat Rovira i Virgili, Barcelona, Spain. [Akova M] Infectious Diseases Department, Hacettepe University School of Medicine, Ankara, Turkey. [Araos R] Infectious Diseases Department, Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina, Clínica Alemana, Universidad del Desarrollo, Santiago de Chile, Chile. [Ruiz-Camps I] Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Spain |
dc.identifier.pmid | 31129580 |
dc.identifier.wos | WOS:000471192800144 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |